Literature DB >> 2390420

The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione.

P J Ciaccio1, K D Tew, F P LaCreta.   

Abstract

Incubation of 100 microM chlorambucil (CMB) with 1 mM glutathione (GSH) in 0.1 M potassium phosphate buffer yielded a mixture of GSH conjugates and hydrolytic products that were separable by HPLC. The appearance in HPLC analysis of four of these products was GSH-dependent. 35S-Label from 35S-GSH eluted with all four chemical species that also gave UV spectra characteristic of CMB-containing compounds. Mass spectral analysis of three of these compounds gave molecular weights consistent with the following adducts: adduct 2: diglutathionyl CMB; adduct 3: monohydroxy monochloroglutathionyl CMB; adduct 4: monochloro monoglutathionyl CMB. Purified GST alpha and partially pure GST pi and mu class protein prepared from adult male mouse liver cytosol significantly increased the formation of the monoglutathionyl CMB adduct. At 5 min incubations, this adduct was quantitatively most important and was increased 4.4-fold by the addition of GST alpha isozymes. At 1 hr incubations, all four adducts were measurable, although enzymes primarily affected the formation of adduct 4. At 1 hr, addition of GST alpha, pi, or mu protein increased the production of monochloro monoglutathionyl CMB 2-fold, 1.5-fold, and 1.7-fold, respectively, demonstrating that CMB is indeed a substrate for GST isozymes in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390420     DOI: 10.3727/095535490820874263

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  12 in total

Review 1.  Adaptive response to glutathione S-transferase inhibitors.

Authors:  P J Ciaccio; K D Tew
Journal:  Br J Cancer Suppl       Date:  1996-07

2.  Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols.

Authors:  K Zhang; K P Wong
Journal:  Biochem J       Date:  1997-07-15       Impact factor: 3.857

3.  Structural and Biochemical Analyses Reveal the Mechanism of Glutathione S-Transferase Pi 1 Inhibition by the Anti-cancer Compound Piperlongumine.

Authors:  Wayne Harshbarger; Sudershan Gondi; Scott B Ficarro; John Hunter; Durga Udayakumar; Deepak Gurbani; William D Singer; Yan Liu; Lianbo Li; Jarrod A Marto; Kenneth D Westover
Journal:  J Biol Chem       Date:  2016-11-21       Impact factor: 5.157

4.  Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide.

Authors:  J D Hayes; D J Judah; G E Neal; T Nguyen
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver.

Authors:  P K Srivastava; D J Waxman
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

Review 6.  Glutathione-related enzymes, glutathione and multidrug resistance.

Authors:  J A Moscow; K H Dixon
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

7.  Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine.

Authors:  V Gupta; J P Jani; S Jacobs; M Levitt; L Fields; S Awasthi; B H Xu; M Sreevardhan; Y C Awasthi; S V Singh
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Increased levels of glutathione S-transferase pi transcript as a mechanism of resistance to ethacrynic acid.

Authors:  S Kuzmich; L A Vanderveer; E S Walsh; F P LaCreta; K D Tew
Journal:  Biochem J       Date:  1992-01-01       Impact factor: 3.857

9.  Forced evolution of glutathione S-transferase to create a more efficient drug detoxication enzyme.

Authors:  A M Gulick; W E Fahl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

10.  Intracellular glutathione and cytotoxicity of platinum complexes.

Authors:  L Pendyala; P J Creaven; R Perez; J R Zdanowicz; D Raghavan
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.